Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2008 3
2009 7
2010 3
2011 7
2012 6
2013 5
2014 7
2015 5
2016 4
2017 7
2018 5
2019 10
2020 19
2021 19
2022 21
2023 14
2024 21
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with Infliximab: a case-based review.
Keshavamurthy C, Fibeger E, Virata A, Bansal P. Keshavamurthy C, et al. ARP Rheumatol. 2022 Oct-Dec;1(4):322-327. ARP Rheumatol. 2022. PMID: 36617314 Free article. Review. English.
BACKGROUND: SDRIFE is a rare cutaneous eruption characterized by symmetrical intertriginous dermatitis, caused by delayed Type-IV immune reaction, with several reported drug-triggers. ...
BACKGROUND: SDRIFE is a rare cutaneous eruption characterized by symmetrical intertriginous dermatitis, caused by delayed Type …
Symmetrical Drug-related Intertriginous and Flexural Exanthema (Baboon Syndrome).
Lima Miranda O, Martins J, Almeida A, Formigo M, Pereira O, Rocha M, Cotter J. Lima Miranda O, et al. Eur J Case Rep Intern Med. 2021 Dec 2;8(12):003029. doi: 10.12890/2021_003029. eCollection 2021. Eur J Case Rep Intern Med. 2021. PMID: 35059336 Free PMC article.
Baboon syndrome, also called symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), is an erythematous maculopapular rash that presents in skin folds in a symmetrical pattern. ...Lesions continued to progressively …
Baboon syndrome, also called symmetrical drug-related intertriginous and flexural exanthema (SDRIF …
Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
Schuler AM, Smith EH, Chaudet KM, Bresler SC, Gudjonsson JE, Kroshinsky D, Nazarian RM, Chan MP. Schuler AM, et al. J Cutan Pathol. 2021 Dec;48(12):1471-1479. doi: 10.1111/cup.14090. Epub 2021 Jul 8. J Cutan Pathol. 2021. PMID: 34159622 Free article. Review.
BACKGROUND: Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a cutaneous drug reaction characterized by gluteal/anogenital erythema and symmetric involvement of other intertriginous location(s) withou …
BACKGROUND: Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a cutaneous d …
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) after administration of corticosteroids: Case series and review of literature.
Steininger J, Bauer A, Hasler H, Beissert S, Abraham S. Steininger J, et al. Contact Dermatitis. 2024 Aug;91(2):146-151. doi: 10.1111/cod.14594. Epub 2024 May 20. Contact Dermatitis. 2024. PMID: 38769741 Review.
BACKGROUND: Cutaneous manifestations of drug-induced type IV reactions vary widely, with symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) being a less common presentation. ...
BACKGROUND: Cutaneous manifestations of drug-induced type IV reactions vary widely, with symmetrical drug-related in
Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
Patel RT, Quan EY, Eikenberg JD, Grider DJ, Phillips MA. Patel RT, et al. Dermatol Online J. 2023 Aug 15;29(4). doi: 10.5070/D329461905. Dermatol Online J. 2023. PMID: 37921816 Free article.
Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a cutaneous drug reaction that presents with symmetrical erythema in the flexures. ...This case highlights the importance of considering SDRIFE in the differe
Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a cutaneous drug reaction
Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine.
Di Bona D, Miniello A, Nettis E. Di Bona D, et al. Clin Mol Allergy. 2022 Dec 12;20(1):13. doi: 10.1186/s12948-022-00179-8. Clin Mol Allergy. 2022. PMID: 36503530 Free PMC article.
Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure. ...
Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which ma …
Symmetrical drug-related intertriginous and flexural exanthema.
Tan SC, Tan JW. Tan SC, et al. Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):313-8. doi: 10.1097/ACI.0b013e3283489d5f. Curr Opin Allergy Clin Immunol. 2011. PMID: 21659857 Review.
PURPOSE OF REVIEW: Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), previously termed drug-related baboon syndrome, is a benign and self-limiting type IV hypersensitivity reaction characterized by …
PURPOSE OF REVIEW: Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), previo …
146 results